“…Both studies found a significant correlation between RMK metrics and clinical outcomes (upper limb Fugl-Meyer Assessment (Agrafiotis et al, 2021;Moretti et al, 2021), Motor Power (Agrafiotis et al, 2021), NIH stroke scale (Agrafiotis et al, 2021), modified Rankin scale (Agrafiotis et al, 2021), Wolf Motor Function Test (Moretti et al, 2021), Barthel Index (Moretti et al, 2021), and Medical Research Council score (Moretti et al, 2021) demonstrating that traditional stroke assessment scales can be accurately reproduced by robotic measurements. The outcomes of these studies pave the way for the use of RMK data to reduce the sample size needed for future clinical trials on chronic stroke patients (Agrafiotis et al, 2021) and to objectively, quantitatively, and rapidly assess impairments in body function (Moretti et al, 2021). However, most published studies on this topic examined the relationships between technology-based metrics and clinical assessment outcomes measured close in time (e.g., concurrently) (Krebs et al, 2014;Grimm et al, 2021;Olesh et al, 2014;Wang et al, 1109).…”